Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Gilead Sciences, Inc
MIL:1GILD
Gilead Sciences, Inc
MIL:1GILD
Price:
132.88
EUR
-1.26%
Market Cap:
€165.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Gilead Sciences, Inc
MIL:1GILD
|
US |
|
A
|
AP Biosciences Inc
TPEX:6945
|
TW |
|
G
|
G-Able PCL
SET:GABLE
|
TH |
Wall St Price Targets
1GILD Price Forecast
Based on 32 analysts
Based on 32 analysts
+12% Upside
from
€132.88
today
Gilead Sciences, Inc (1GILD)’s 12-month stock price forecast through October 2027 has a consensus target of €149.33, implying 12% upside. The forecast is based on price targets from 32 Wall Street analysts.
1GILD Analyst Rating
No ratings yet
No ratings yet
Gilead Sciences, Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1GILD's stock price target?
Price Target
149.33
EUR
149.33
EUR
According to Wall Street analysts, the average 1-year price target for 1GILD is 149.33 EUR with a low forecast of 110.23 EUR and a high forecast of 167.69 EUR.
What is the Revenue forecast for Gilead Sciences, Inc?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Gilead Sciences, Inc?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Gilead Sciences, Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.
What is the Pre-Tax Income forecast for Gilead Sciences, Inc?
Projected CAGR
19%
19%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Gilead Sciences, Inc?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 9%.